180 related articles for article (PubMed ID: 11913249)
1. Impact factors on development of cirrhosis and subsequent hepatocellular carcinoma.
Holmes-McNary M
Compend Contin Educ Dent; 2001 Jul; 22(3 Spec No):19-33. PubMed ID: 11913249
[TBL] [Abstract][Full Text] [Related]
2. [Role of environmental factors in the etiology of hepatocellular carcinoma].
Tornai I
Orv Hetil; 2010 Jul; 151(28):1132-6. PubMed ID: 20570793
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
Fan JG; Farrell GC;
J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
[TBL] [Abstract][Full Text] [Related]
4. Environmental factors and risk for hepatocellular carcinoma.
Yu MC; Yuan JM
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S72-8. PubMed ID: 15508106
[TBL] [Abstract][Full Text] [Related]
5. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hepatocellular carcinoma: progress and challenges.
Shire AM; Roberts LR
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):49-64. PubMed ID: 22419004
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
Kaczynski J
Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
[TBL] [Abstract][Full Text] [Related]
9. Role of antiviral therapy in the prevention of hepatocellular carcinoma.
Franco J; Saeian K
J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S191-6. PubMed ID: 12354836
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U
Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436
[TBL] [Abstract][Full Text] [Related]
11. Emerging therapies of hepatitis B and C.
Chen RY; Desmond PV; Locarnini SA
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S471-81. PubMed ID: 12534781
[No Abstract] [Full Text] [Related]
12. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
[TBL] [Abstract][Full Text] [Related]
13. Liver cancer and alcohol.
Grewal P; Viswanathen VA
Clin Liver Dis; 2012 Nov; 16(4):839-50. PubMed ID: 23101985
[TBL] [Abstract][Full Text] [Related]
14. Smoking, hepatitis B virus infection, and development of hepatocellular carcinoma.
Sherman M; Llovet JM
J Natl Cancer Inst; 2011 Nov; 103(22):1642-3. PubMed ID: 22021668
[No Abstract] [Full Text] [Related]
15. Non-viral causes of hepatocellular carcinoma.
Blonski W; Kotlyar DS; Forde KA
World J Gastroenterol; 2010 Aug; 16(29):3603-15. PubMed ID: 20677332
[TBL] [Abstract][Full Text] [Related]
16. Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?
Joshi K; Kohli A; Manch R; Gish R
Clin Liver Dis; 2016 Aug; 20(3):563-80. PubMed ID: 27373617
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
Trichopoulos D; Bamia C; Lagiou P; Fedirko V; Trepo E; Jenab M; Pischon T; Nöthlings U; Overved K; Tjønneland A; Outzen M; Clavel-Chapelon F; Kaaks R; Lukanova A; Boeing H; Aleksandrova K; Benetou V; Zylis D; Palli D; Pala V; Panico S; Tumino R; Sacerdote C; Bueno-De-Mesquita HB; Van Kranen HJ; Peeters PH; Lund E; Quirós JR; González CA; Sanchez Perez MJ; Navarro C; Dorronsoro M; Barricarte A; Lindkvist B; Regnér S; Werner M; Hallmans G; Khaw KT; Wareham N; Key T; Romieu I; Chuang SC; Murphy N; Boffetta P; Trichopoulou A; Riboli E
J Natl Cancer Inst; 2011 Nov; 103(22):1686-95. PubMed ID: 22021666
[TBL] [Abstract][Full Text] [Related]
18. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
[TBL] [Abstract][Full Text] [Related]
20. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
